Causal relationship between immune cells and the risk of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis: A Mendelian randomization study

被引:0
|
作者
Cai, Xiaojing [1 ]
Li, Junhua [1 ]
Wu, Manyi [1 ]
Liu, Qingquan [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Nephrol, Wuhan, Peoples R China
来源
FASEB JOURNAL | 2024年 / 38卷 / 14期
关键词
ANCA; causal inference; genome-wide association study; immunity; myeloperoxidase; randomization analysis; REGULATORY T-CELLS; EOSINOPHILIC GRANULOMATOSIS; CD8(+) CD28(-); B-CELLS; SERUM; CD8(+)CD28(-); LYMPHOCYTES; EXPRESSION; REMISSION; INCREASES;
D O I
10.1096/fj.202400141R
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare inflammatory disease categorized as antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. The majority of patients are ANCA-positive, predominantly against myeloperoxidase (MPO). Previous studies have predominantly concentrated on the association between EGPA and neutrophils, but recent research has emphasized the role of lymphocytes in the development of EGPA. The objective of our research was to examine the causal association between immune cells and MPO + ANCA EGPA. A two-sample bidirectional Mendelian randomization (MR) analysis was performed, which included 159 MPO + ANCA EGPA cases and 6688 controls and utilized Genome-Wind Associaton Studies (GWAS) summary statistics of immune traits from approximately 3757 individuals, encompassing around 22 million single nucleotide polymorphisms (SNPs). Our findings revealed that 23 immunophenotypes were associated with MPO + ANCA EGPA. Furthermore, the reverse MR analysis showed that MPO + ANCA EGPA had significant causal effects on three immunophenotypes within the Treg panel. By integrating existing research, our study unveiled the contributions of Tregs, B cells, and monocytes to the development of EGPA. Subgroup analysis specifically examined the roles of lymphocyte subtypes, cytokines, and their surface molecules in the pathogenic mechanisms of the disease. This comprehensive approach provides a novel perspective on the biological mechanisms and early intervention strategies for MPO + ANCA EGPA by focusing on immune cells.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis
    Arnold, Sabrina
    Kitching, Arichard
    Witko-Sarsat, Veronique
    Wiech, Thorsten
    Specks, Ulrich
    Klapa, Sebastian
    Comduehr, Sara
    Staehle, Anja
    Mueller, Antje
    Lamprecht, Peter
    LANCET RHEUMATOLOGY, 2024, 6 (05): : e300 - e313
  • [2] Myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with diffuse tubulointerstitial nephritis
    Son, Daisuke
    Kanda, Hiroko
    Yamaguchi, Akihiro
    Kawabata, Kimito
    Kawakami, Takahisa
    Kubo, Kanae
    Higashihara, Mana
    Shimizu, Jun
    Uozaki, Hiroshi
    Kuramochi, Shigeru
    Misaki, Yoshikata
    Takeuchi, Fujio
    Yamamoto, Kazuhiko
    JOURNAL OF NEPHROLOGY, 2009, 22 (03) : 417 - 420
  • [3] Clinical analysis of patients with myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis
    Shuai, Z. W.
    Lv, Y. F.
    Zhang, M. M.
    Hu, Z. Y.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02): : 5296 - 5303
  • [4] Epipharyngeal Inflammation in Myeloperoxidase-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Nunokawa, Takahiro
    Kise, Takayasu
    Masukawa, Ai
    Yokogawa, Naoto
    Shimada, Kota
    Sigii, Shoji
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 (05) : E133 - E134
  • [5] ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS IN
    Popescu, M. L.
    Predeteanu, D.
    Opris-Belinski, D.
    Balanescu, A.
    Berghea, F.
    Borangiu, A.
    Constantinescu, C.
    Groseanu, L.
    Ionescu, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (01) : S27 - S28
  • [6] Antineutrophil cytoplasmic antibody-associated vasculitis
    Konda, Raghunandan
    Rajasekaran, Arun
    Rizk, Dana V.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2024, 33 (05): : 503 - 511
  • [7] Myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis following propylthiouracil therapy
    Otsuka, S
    Kinebuchi, A
    Tabata, H
    Yamakage, A
    Yamazaki, S
    BRITISH JOURNAL OF DERMATOLOGY, 2000, 142 (04) : 828 - 830
  • [8] Aortic aneurysm as a complication of myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis
    Satomura, Atsushi
    Fujita, Takayuki
    Maruyama, Takashi
    Hamada, Hiroaki
    Nozawa, Yukinari
    Takayama, Eiichi
    Maruyama, Toshiharu
    Nakayama, Tomohiro
    OPEN MEDICINE, 2017, 12 (01): : 468 - 473
  • [9] Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis
    Walsh, Michael
    Flossmann, Oliver
    Berden, Annelies
    Westman, Kerstin
    Hoglund, Peter
    Stegeman, Coen
    Jayne, David
    ARTHRITIS AND RHEUMATISM, 2012, 64 (02): : 542 - 548
  • [10] RISK FACTORS ASSOCIATED WITH RELAPSE OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS
    Nakahara, M.
    Yamashita, H.
    Takahashi, Y.
    Araki, K.
    Mino, N.
    Suga, K.
    Yashima, A.
    Kaneko, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1484 - 1484